收购交易概述 - 公司赛默飞世尔将以约89亿美元现金及未来付款方式收购私人控股的数据管理公司Clario [1] - 此次收购旨在加强公司在数字健康和临床研究领域的业务布局 [1] 战略影响 - 收购将增强公司在临床试验研究领域的实力 [1]

Clinical trial recruitment platform Trially has raised $4.7m in a seed funding round and introduced its agentic AI solution, Margo, designed to increase study enrolment by converting patient matches into actual subjects. The company said that 86% of trials experience delays due to recruitment issues, resulting in the pharma industry incurring significant losses daily, while patients endure lengthy waits for potentially life-saving treatments. As the first fully integrated AI platform designed to address ...